CD36 mediates the uptake of long-chain fatty acids (FAs), a major energy substrate for the myocardium. Under excessive FA supply, CD36 can cause cardiac lipid accumulation and inflammation while its deletion reduces heart FA uptake and lipid content and increases glucose utilization. As a result, CD36 was proposed as a therapeutic target for obesity-associated heart disease. However, more recent reports have shown that CD36 deficiency suppresses myocardial flexibility in fuel preference between glucose and FAs, impairing tissue energy balance, while CD36 absence in tissue macrophages reduces efferocytosis and myocardial repair after injury. In line with the latter homeostatic functions, we had previously reported that CD36-/- mice have chronic subclinical inflammation. Lipids are important for the maintenance of tissue homeostasis and there is limited information on heart lipid metabolism in CD36 deficiency. Here, we document in the hearts of unchallenged CD36-/- mice abnormalities in the metabolism of triglycerides, plasmalogens, cardiolipins, acylcarnitines, and arachidonic acid, and the altered remodeling of these lipids in response to an overnight fast. The hearts were examined for evidence of inflammation by monitoring the presence of neutrophils and pro-inflammatory monocytes/macrophages using the respective positron emission tomography (PET) tracers, 64Cu-AMD3100 and 68Ga-DOTA-ECL1i. We detected significant immune cell infiltration in unchallenged CD36-/- hearts as compared with controls and immune infiltration was also observed in hearts of mice with cardiomyocyte-specific CD36 deficiency. Together, the data show that the CD36-/- heart is in a non-homeostatic state that could compromise its stress response. Non-invasive immune cell monitoring in humans with partial or total CD36 deficiency could help evaluate the risk of impaired heart remodeling and disease.

Department of Cell Biology and Physiology Washington University School of Medicine St Louis MO United States

Department of Medicine Washington University School of Medicine St Louis MO United States

Department of Pharmacology and Physiology Saint Louis University School of Medicine St Louis MO United States

Department of Radiology Washington University School of Medicine St Louis MO United States

Division of Complex Drug Analysis Office of Testing and Research U S Food and Drug Administration St Louis MO United States

Division of Endocrinology Department of Medicine New York University Grossman School of Medicine New York NY United States

Institute of Physiology Czech Academy of Sciences Prague Czechia

Zobrazit více v PubMed

Hames KC, Vella A, Kemp BJ, Jensen MD. Free fatty acid uptake in humans with CD36 deficiency. Diabetes. (2014) 63:3606–14. PubMed PMC

Carley AN, Bi J, Wang X, Banke NH, Dyck JR, O’Donnell JM, et al. Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36. J Lipid Res. (2013) 54:97–106. 10.1194/jlr.M029991 PubMed DOI PMC

Glatz JFC, Luiken J, Nabben M. CD36 (SR-B2) as a target to treat lipid overload-induced cardiac dysfunction. J Lipid Atheroscler. (2020) 9:66–78. 10.12997/jla.2020.9.1.66 PubMed DOI PMC

Pietka TA, Sulkin MS, Kuda O, Wang W, Zhou D, Yamada KA, et al. CD36 protein influences myocardial Ca2+ homeostasis and phospholipid metabolism: conduction anomalies in CD36-deficient mice during fasting. J Biol Chem. (2012) 287:38901–12. 10.1074/jbc.M112.413609 PubMed DOI PMC

Okamoto F, Tanaka T, Sohmiya K, Kawamura K. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy. Jpn Circ J. (1998) 62:499–504. 10.1253/jcj.62.499 PubMed DOI

Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, Kusaka Y, et al. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J Lipid Res. (2001) 42:751–9. PubMed

Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol. (1997) 29:121–7. PubMed

Abumrad NA, Goldberg IJ. CD36 actions in the heart: lipids, calcium, inflammation, repair and more? Biochim Biophys Acta. (2016) 1861:1442–9. 10.1016/j.bbalip.2016.03.015 PubMed DOI PMC

Forte E, Furtado MB, Rosenthal N. The interstitium in cardiac repair: role of the immune-stromal cell interplay. Nat Rev Cardiol. (2018) 15:601–16. 10.1038/s41569-018-0077-x PubMed DOI

Gentek R, Hoeffel G. The innate immune response in myocardial infarction repair, and regeneration. Adv Exp Med Biol. (2017) 1003:251–72. PubMed

Weinberger T, Schulz C. Myocardial infarction: a critical role of macrophages in cardiac remodeling. Front Physiol. (2015) 6:107. 10.3389/fphys.2015.00107 PubMed DOI PMC

Shinagawa H, Frantz S. Cellular immunity and cardiac remodeling after myocardial infarction: role of neutrophils, monocytes, and macrophages. Curr Heart Fail Rep. (2015) 12:247–54. PubMed

Swirski FK. Inflammation and repair in the ischaemic myocardium. Hamostaseologie. (2015) 35:34–6. PubMed

Cavalera M, Frangogiannis NG. Targeting the chemokines in cardiac repair. Curr Pharm Des. (2014) 20:1971–9. PubMed PMC

Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. (2003) 19:71–82. 10.1016/s1074-7613(03)00174-2 PubMed DOI

Nahrendorf M, Swirski FK. PET Imaging of Leukocytes in Patients With Acute Myocardial Infarction. JACC Cardiovasc Imaging. (2015) 8:1427–9. PubMed

Frangogiannis NG. The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. J Am Coll Cardiol. (2011) 58:2424–6. PubMed

Nishimura Y, Ii M, Qin G, Hamada H, Asai J, Takenaka H, et al. CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol. (2012) 132(3 Pt 1):711–20. PubMed PMC

Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T, et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA. (2010) 107:11008–13. 10.1073/pnas.0914248107 PubMed DOI PMC

Irie H, Krukenkamp IB, Brinkmann JF, Gaudette GR, Saltman AE, Jou W, et al. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci USA. (2003) 100:6819–24. PubMed PMC

Dehn S, Thorp EB. Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair. FASEB J. (2018) 32:254–64. 10.1096/fj.201700450R PubMed DOI PMC

Cifarelli V, Ivanov S, Xie Y, Son NH, Saunders BT, Pietka TA, et al. CD36 deficiency impairs the small intestinal barrier and induces subclinical inflammation in mice. Cell Mol Gastroenterol Hepatol. (2017) 3:82–98. 10.1016/j.jcmgh.2016.09.001 PubMed DOI PMC

Shibao CA, Celedonio JE, Ramirez CE, Love-Gregory L, Arnold AC, Choi L, et al. A common CD36 variant influences endothelial function and response to treatment with phosphodiesterase 5 inhibition. J Clin Endocrinol Metab. (2016) 101:2751–8. 10.1210/jc.2016-1294 PubMed DOI PMC

Love-Gregory L, Kraja AT, Allum F, Aslibekyan S, Hedman AK, Duan Y, et al. Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36. J Lipid Res. (2016) 57:2176–84. 10.1194/jlr.P065250 PubMed DOI PMC

Zhao Y, Detering L, Sultan D, Cooper ML, You M, Cho S, et al. Gold nanoclusters doped with (64)Cu for CXCR4 positron emission tomography imaging of breast cancer and metastasis. ACS Nano. (2016) 10:5959–70. 10.1021/acsnano.6b01326 PubMed DOI PMC

Heo GS, Kopecky B, Sultan D, Ou M, Feng G, Bajpai G, et al. Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart. Circ Res. (2019) 124:881–90. 10.1161/CIRCRESAHA.118.314030 PubMed DOI PMC

Son NH, Basu D, Samovski D, Pietka TA, Peche VS, Willecke F, et al. Endothelial cell CD36 optimizes tissue fatty acid uptake. J Clin Invest. (2018) 128:4329–42. 10.1172/JCI99315 PubMed DOI PMC

Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev. (2012) 31:134–78. 10.1002/mas.20342 PubMed DOI PMC

Liu X, Moon SH, Mancuso DJ, Jenkins CM, Guan S, Sims HF, et al. Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation. Anal Biochem. (2013) 442:40–50. 10.1016/j.ab.2013.06.014 PubMed DOI PMC

Han X, Yang J, Cheng H, Ye H, Gross RW. Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. Anal Biochem. (2004) 330:317–31. 10.1016/j.ab.2004.04.004 PubMed DOI

Ford DA, Han X, Horner CC, Gross RW. Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool. Biochemistry. (1996) 35:7903–9. 10.1021/bi960552n PubMed DOI

Su X, Han X, Mancuso DJ, Abendschein DR, Gross RW. Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics. Biochemistry. (2005) 44:5234–45. 10.1021/bi047773a PubMed DOI

Spiekerkoetter U, Tokunaga C, Wendel U, Mayatepek E, Ijlst L, Vaz FM, et al. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice. Pediatr Res. (2005) 57:760–4. PubMed

Kuda O, Rombaldova M, Janovska P, Flachs P, Kopecky J. Cell type-specific modulation of lipid mediator’s formation in murine adipose tissue by omega-3 fatty acids. Biochem Biophys Res Commun. (2016) 469:731–6. 10.1016/j.bbrc.2015.12.055 PubMed DOI

McDonnell E, Crown SB, Fox DB, Kitir B, Ilkayeva OR, Olsen CA, et al. Lipids reprogram metabolism to become a major carbon source for histone acetylation. Cell Rep. (2016) 17:1463–72. 10.1016/j.celrep.2016.10.012 PubMed DOI PMC

Clemot M, Senos Demarco R, Jones DL. Lipid mediated regulation of adult stem cell behavior. Front Cell Dev Biol. (2020) 8:115. 10.3389/fcell.2020.00115 PubMed DOI PMC

Saddik M, Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol. (1994) 72:1110–9. 10.1139/y94-157 PubMed DOI

Park H, He A, Tan M, Johnson JM, Dean JM, Pietka TA, et al. Peroxisome-derived lipids regulate adipose thermogenesis by mediating cold-induced mitochondrial fission. J Clin Invest. (2019) 129:694–711. 10.1172/JCI120606 PubMed DOI PMC

Ito K, Carracedo A, Weiss D, Arai F, Ala U, Avigan DE, et al. A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med. (2012) 18:1350–8. 10.1038/nm.2882 PubMed DOI PMC

Shu H, Peng Y, Hang W, Nie J, Zhou N, Wang DW. The role of CD36 in cardiovascular disease. Cardiovasc Res. (2022) 118:115–29. PubMed PMC

Jenkins CM, Cedars A, Gross RW. Eicosanoid signalling pathways in the heart. Cardiovasc Res. (2009) 82:240–9. PubMed PMC

Kuda O, Jenkins CM, Skinner JR, Moon SH, Su X, Gross RW, et al. CD36 protein is involved in store-operated calcium flux, phospholipase A2 activation, and production of prostaglandin E2. J Biol Chem. (2011) 286:17785–95. 10.1074/jbc.M111.232975 PubMed DOI PMC

Mouton AJ, Li X, Hall ME, Hall JE. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ Res. (2020) 126:789–806. 10.1161/CIRCRESAHA.119.312321 PubMed DOI PMC

Werz O, Gerstmeier J, Libreros S, De la Rosa X, Werner M, Norris PC, et al. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun. (2018) 9:59. 10.1038/s41467-017-02538-5 PubMed DOI PMC

Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: an organizing principle in biology and medicine. Pharmacol Ther. (2021) 227:107879. 10.1016/j.pharmthera.2021.107879 PubMed DOI

Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. (2019) 10:1084. 10.3389/fimmu.2019.01084 PubMed DOI PMC

Eash KJ, Means JM, White DW, Link DC. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood. (2009) 113:4711–9. 10.1182/blood-2008-09-177287 PubMed DOI PMC

De Filippo K, Rankin SM. CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease. Eur J Clin Invest. (2018) 48(Suppl. 2):e12949. 10.1111/eci.12949 PubMed DOI PMC

Vafadarnejad E, Rizzo G, Krampert L, Arampatzi P, Arias-Loza AP, Nazzal Y, et al. Dynamics of cardiac neutrophil diversity in murine myocardial infarction. Circ Res. (2020) 127:e232–49. PubMed

Bajpai G, Bredemeyer A, Li W, Zaitsev K, Koenig AL, Lokshina I, et al. Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circ Res. (2019) 124:263–78. 10.1161/CIRCRESAHA.118.314028 PubMed DOI PMC

Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med (2018) 24:1234–45. 10.1038/s41591-018-0059-x PubMed DOI PMC

Xia Y, Frangogiannis NG. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets. (2007) 6:101–7. PubMed

Luehmann HP, Pressly ED, Detering L, Wang C, Pierce R, Woodard PK, et al. PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle. J Nucl Med. (2014) 55:629–34. 10.2967/jnumed.113.132001 PubMed DOI PMC

Hazen SL, Hall CR, Ford DA, Gross RW. Isolation of a human myocardial cytosolic phospholipase A2 isoform. Fast atom bombardment mass spectroscopic and reverse-phase high pressure liquid chromatography identification of choline and ethanolamine glycerophospholipid substrates. J Clin Invest. (1993) 91:2513–22. 10.1172/JCI116487 PubMed DOI PMC

Li W, Hsiao HM, Higashikubo R, Saunders BT, Bharat A, Goldstein DR, et al. Heart-resident CCR2(+) macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling. JCI Insight. (2016) 1:e87315. 10.1172/jci.insight.87315 PubMed DOI PMC

Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. (1995) 181:1857–62. 10.1084/jem.181.5.1857 PubMed DOI PMC

Zlatanova I, Pinto C, Silvestre JS. Immune modulation of cardiac repair and regeneration: the art of mending broken hearts. Front Cardiovasc Med. (2016) 3:40. 10.3389/fcvm.2016.00040 PubMed DOI PMC

Phillipson M, Kubes P. The healing power of neutrophils. Trends Immunol. (2019) 40:635–47. PubMed

Horckmans M, Ring L, Duchene J, Santovito D, Schloss MJ, Drechsler M, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. (2017) 38:187–97. 10.1093/eurheartj/ehw002 PubMed DOI

Bharadwaj KG, Hiyama Y, Hu Y, Huggins LA, Ramakrishnan R, Abumrad NA, et al. Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake. J Biol Chem. (2010) 285:37976–86. 10.1074/jbc.M110.174458 PubMed DOI PMC

Glatz JFC, Zuurbier CJ, Larsen TS. Targeting metabolic pathways to treat cardiovascular diseases. Biochim Biophys Acta Mol Basis Dis. (2020) 1866:165879. PubMed

Augustus A, Yagyu H, Haemmerle G, Bensadoun A, Vikramadithyan RK, Park SY, et al. Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression. J Biol Chem. (2004) 279:25050–7. 10.1074/jbc.M401028200 PubMed DOI

Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem. (2006) 281:8716–23. PubMed

Li J, Romestaing C, Han X, Li Y, Hao X, Wu Y, et al. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab. (2010) 12:154–65. PubMed PMC

Mancuso DJ, Sims HF, Han X, Jenkins CM, Guan SP, Yang K, et al. Genetic ablation of calcium-independent phospholipase A2gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype. J Biol Chem. (2007) 282:34611–22. 10.1074/jbc.M707795200 PubMed DOI PMC

Minkler PE, Hoppel CL. Separation and characterization of cardiolipin molecular species by reverse-phase ion pair high-performance liquid chromatography-mass spectrometry. J Lipid Res. (2010) 51:856–65. 10.1194/jlr.D002857 PubMed DOI PMC

Xu Y, Malhotra A, Ren M, Schlame M. The enzymatic function of tafazzin. J Biol Chem. (2006) 281:39217–24. PubMed

Werdich AA, Baudenbacher F, Dzhura I, Jeyakumar LH, Kannankeril PJ, Fleischer S, et al. Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice. Am J Physiol Heart Circ Physiol. (2007) 292:H2202–11. 10.1152/ajpheart.00382.2006 PubMed DOI

Gelinas R, Thompson-Legault J, Bouchard B, Daneault C, Mansour A, Gillis MA, et al. Prolonged QT interval and lipid alterations beyond beta-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts. Am J Physiol Heart Circ Physiol. (2011) 301:H813–23. 10.1152/ajpheart.01275.2010 PubMed DOI PMC

Pike LJ, Han X, Chung KN, Gross RW. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry. (2002) 41:2075–88. 10.1021/bi0156557 PubMed DOI

Khaselev N, Murphy RC. Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation. Free Radic Biol Med. (1999) 26:275–84. 10.1016/s0891-5849(98)00211-1 PubMed DOI

Skaff O, Pattison DI, Davies MJ. The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry. (2008) 47:8237–45. 10.1021/bi800786q PubMed DOI

Dean JM, Lodhi IJ. Structural and functional roles of ether lipids. Protein Cell. (2018) 9:196–206. PubMed PMC

Thukkani AK, Hsu FF, Crowley JR, Wysolmerski RB, Albert CJ, Ford DA. Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal. J Biol Chem. (2002) 277:3842–9. 10.1074/jbc.M109489200 PubMed DOI

Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. (2013) 14:812–20. 10.1038/ni.2639 PubMed DOI PMC

Batchu SN, Lee SB, Qadhi RS, Chaudhary KR, El-Sikhry H, Kodela R, et al. Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. Br J Pharmacol. (2011) 162:897–907. 10.1111/j.1476-5381.2010.01093.x PubMed DOI PMC

Spiecker M, Liao JK. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys. (2005) 433:413–20. PubMed

Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood. (1996) 87:2020–8. PubMed

Goyal T, Mitra S, Khaidakov M, Wang X, Singla S, Ding Z, et al. Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep. (2012) 14: 150–9. PubMed

Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. (2010) 11:155–61. 10.1038/ni.1836 PubMed DOI PMC

Ballesteros I, Cuartero MI, Pradillo JM, de la Parra J, Perez-Ruiz A, Corbi A, et al. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARgamma and 5-LO-dependent pathways. J Leukoc Biol. (2014) 95:587–98. 10.1189/jlb.0613326 PubMed DOI

Glinton KE, Ma W, Lantz CW, Grigoryeva LS, DeBerge M, Liu X, et al. Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation. J Clin Invest. (2022) 132:e140685. 10.1172/JCI140685 PubMed DOI PMC

Cifarelli V, Appak-Baskoy S, Peche VS, Kluzak A, Shew T, Narendran R, et al. Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells. Nat Commun. (2021) 12:3350. 10.1038/s41467-021-23808-3 PubMed DOI PMC

Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol. (2015) 27:200–15. 10.1016/j.smim.2015.03.004 PubMed DOI PMC

Love-Gregory L, Abumrad NA. CD36 genetics and the metabolic complications of obesity. Curr Opin Clin Nutr Metab Care. (2011) 14:527–34. PubMed PMC

Kintaka T, Tanaka T, Imai M, Adachi I, Narabayashi I, Kitaura Y. CD36 genotype and long-chain fatty acid uptake in the heart. Circ J. (2002) 66:819–25. PubMed

Huang CC, Chang MT, Leu HB, Yin WH, Tseng WK, Wu YW, et al. Association of arachidonic acid-derived lipid mediators with subsequent onset of acute myocardial infarction in patients with coronary artery disease. Sci Rep. (2020) 10:8105. 10.1038/s41598-020-65014-z PubMed DOI PMC